Back to search
FDAFDA · Food and drugs·Recall number D-1509-2014

Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10

Published August 6, 2014 · Recall initiated: July 25, 2014

Summary

FDA records drug Class II recall D-1509-2014, published August 6, 2014 and initiated July 25, 2014. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 1,332 bottles; Lot: Lot EJ9591. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance; tablets may contain stainless steel metal particulates

What to do

Voluntary: Firm initiated · Letter

Get an email if ALPRAZOLAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ALPRAZOLAM
Manufacturer
Sandoz Incorporated
Distributor
Nationwide
Lot
Lot EJ9591
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10 recalled?

Yes. FDA published recall D-1509-2014 on August 6, 2014. Reported hazard: Presence of Foreign Substance; tablets may contain stainless steel metal particulates

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ALPRAZOLAM.